An experimental vaccine being studied at the University of Nebraska Medical Center successfully spurred the development of dopamine-producing nerve cells, reversing the disease in mice. And after more than a decade of work on the vaccine, the scientists are anxious to determine if the same vaccine strategy would also work in humans. Story